← Evidence map

ArticleCytometry. Part B, Clinical cytometry2024

Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies.

Philip G Woost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38345160